FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RAGISTOMIG
异名/同义词IMMUNOGLOBULIN G1 (299-ALANINE), ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN-MUS MUSCULUS CLONE B6 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)3 FUSION PROTEIN WITH IMMUNOGLOBULIN (103-CYSTEINE,174-CYSTEINE) ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR TNFRSF9) (HUMAN CLONE 1A10M12 SINGLE-CHAIN FV FRAGMENT VL-(GGGGS)4-VH), DISULFIDE WITH HUMAN-MUS MUSCULUS CLONE B6 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-SCFV_L-KAPPA DIMER, ANTI-(HOMO SAPIENS CD274 (PROGRAMMED CELL DEATH 1 LIGAND 1, PDL1,PD-L1, B7 HOMOLOG 1, B7H1, B7-H1, PDCD1LG1)) AND ANTI-(HOMO SAPIENS TNFRSF9 (TNF RECEPTOR SUPERFAMILY MEMBER 9, 4-1BB, T CELL ANTIGEN ILA, CD137)), HUMANIZED MONOCLONAL ANTIBODY, BISPECIFIC
RAGISTOMIG
RAGISTOMIG [INN]
RAGISTOMIG [WHO-DD]
CAS登记号2763222-58-6
物质唯一标识(Unique Ingredient Identifier)6W6Z6G78V3
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System